Skip to main content
. Author manuscript; available in PMC: 2015 Nov 25.
Published in final edited form as: J Natl Compr Canc Netw. 2011 Feb;9(0 1):S1–29. doi: 10.6004/jnccn.2011.0124

Figure 1.

Figure 1

Therapeutic targets in renal cell carcinoma.

Abbreviations: HIF, hypoxia-induced factor; mTORC1/2, mammalian target of rapamycin complexes 1 and 2; PDK1, phosphoinositide-dependant kinase-1; PI3K, phosphatidylinositol 3-kinase; RCC, renal cell carcinoma; RTKs, receptor tyrosine kinase; VEGF, vascular endothelial growth factor; VHL, von Hippel-Lindau.

Modified from Courtney KD, Choueiri TK. Optimizing recent advances in metastatic renal cell carcinoma. Curr Oncol Rep 2009;11:218–226; with kind permission from Springer Science+Business Media.